1 reports of this reaction
7.7% of all KALI MURIATICUM reports
#4 most reported adverse reaction
GLIOBLASTOMA MULTIFORME is the #4 most commonly reported adverse reaction for KALI MURIATICUM, manufactured by Bestmade Natural Products. There are 1 FDA adverse event reports linking KALI MURIATICUM to GLIOBLASTOMA MULTIFORME. This represents approximately 7.7% of all 13 adverse event reports for this drug.
Patients taking KALI MURIATICUM who experience glioblastoma multiforme should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GLIOBLASTOMA MULTIFORME is moderately reported among KALI MURIATICUM users, representing a notable but not dominant share of adverse events.
In addition to glioblastoma multiforme, the following adverse reactions have been reported for KALI MURIATICUM:
GLIOBLASTOMA MULTIFORME has been reported as an adverse event in 1 FDA reports for KALI MURIATICUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
GLIOBLASTOMA MULTIFORME accounts for approximately 7.7% of all adverse event reports for KALI MURIATICUM, making it a notable side effect.
If you experience glioblastoma multiforme while taking KALI MURIATICUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.